← Back to headlines
The takeover fever is rampant in the biotechnology industry
More biotech firms are likely to change hands this year than ever before. Many pharmaceutical groups urgently need new products. Roche and Novartis are also on a shopping spree.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
US Inflation Rises as Expected in July, Easing Rate Hike Concerns
28m ago
Serbian Bank Expands into BiH Market, Acquires Macedonian Insurance Company
30m ago
ABN Amro Reports Increased Profit and Raises Outlook Amid Strong Customer Activity
34m ago
Goldman Sachs to Acquire ETF Provider Neos in $2.3 Billion Deal
43m ago